Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
New subclade K flu strain raises concerns: What families should know - 2German petrol stations hike prices as once-a-day rule takes effect
- 3AfD in Brandenburg takes back suit against the intelligence service
- 4Pick Your #1 game to observe
- 5'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Rue's 'Breaking Bad' era
- EU delays signing of Mercosur free trade deal
- Shrapnel hits across central Israel, injuring several, causing property damage
- 6 Well known Ladies' Fragrances On the planet
- Charity 'feels the pinch' of higher energy prices
- Photos: Presidential turkey pardons — a look back
- Which camera do you believe is great for first-time clients? !
- Sentimental tree to shine at Arctic League annual broadcast
- 'People We Meet on Vacation' is the 1st of many Emily Henry adaptations: What other books turned movies to look forward to
- How do my eyes adjust to the dark and how long does it take?
